Friday, June 12, 2026

Patent directory Β· USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code β€” or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1113 of 1,261
  1. EP 1655027

    Verwendung von 9-(N-methyl-piperidyliden-4)-thioxanthene zur Behandlung von pulmoler Hypertension und MigrΓ€ne

    BIOFRONTERA PHARMACEUTICALS GM [DE] Β· Granted May 10, 2006 Β· Expires May 5, 2026

    expired
  2. CA 1341505

    PREPARATION D'IMMUNOGLOBULINE POLYCLONALE CONTENANT DE L'IGM, AUX FINS D'ADMINISTRATION INTRAVEINEUSE, AINSI QUE SA METHODE DE FABRICATION

    BIOTEST PHARMA GMBH [DE] Β· Granted May 9, 2006 Β· Expires May 4, 2026

    expired
  3. US 7041503

    Modified myelin basic protein molecules

    The United States of America, as represented by the Department of Health and Human Services Β· Granted May 9, 2006 Β· Expires May 4, 2026

    expired
  4. US 7041806

    Netrin receptors

    The Regents of the University of California Β· Granted May 9, 2006 Β· Expires May 4, 2026

    expired
  5. US 7041789

    RFRP-3 and DNA thereof

    Takeda Pharmaceutical Company Limited Β· Granted May 9, 2006 Β· Expires May 4, 2026

    expired
  6. US 7041687

    Indazole compounds useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated Β· Granted May 9, 2006 Β· Expires May 4, 2026

    expired
  7. US 7041784

    Apoptotic compounds

    The Board of Regents of the University of Texas System Β· Granted May 9, 2006 Β· Expires May 4, 2026

    expired
  8. US 7041498

    Method for modulating processes mediated by farnesoid activated receptors

    THE GOVERNMENT OF THE UNITED STATES OF AMERICA Β· Granted May 9, 2006 Β· Expires May 4, 2026

    expired
  9. US 7041481

    Chemical amplification based on fluid partitioning

    The Regents of the University of California Β· Granted May 9, 2006 Β· Expires May 4, 2026

    expired
  10. US 7041462

    Conformational and topological protein regulation

    The Regents of the University of California Β· Granted May 9, 2006 Β· Expires May 4, 2026

    expired
  11. US 7041443

    Porcine reproductive and respiratory syndrome virus and methods of use

    Regents of the University of Minnesota Β· Granted May 9, 2006 Β· Expires May 4, 2026

    expired
  12. US 7041296

    Methods of treating inflammatory bowel disease using cholera toxin B subunit

    The United States of America, as represented by the Department of Health and Human Services Β· Granted May 9, 2006 Β· Expires May 4, 2026

    expired
  13. US 7037533

    Functional agent for decomposing nicotine and method of preparing the same

    REGENBiotech, Inc. Β· Granted May 2, 2006 Β· Expires Apr 27, 2026

    expired
  14. US 7038060

    Synthesis of 2-butyl-3-(2β€²-(1-trityl-1H-tetrazol-5-yl)biphenyl-4-yl)-1,3-diazaspiro[4.4]-non-ene-4-one

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. Β· Granted May 2, 2006 Β· Expires Apr 27, 2026

    expired
  15. US 7037912

    Protein kinase inhibitors

    Theravance, Inc. Β· Granted May 2, 2006 Β· Expires Apr 27, 2026

    expired
  16. US 7037904

    Use of N-acetyl-D-glucosamine in the manufacture of pharmaceutical useful for suppressing side-effect of radiotherapy and chemotherapy

    Third Military Medical University, Chinese People's Liberation Army, P.R. of China Β· Granted May 2, 2006 Β· Expires Apr 27, 2026

    expired
  17. US 7037901

    Radiosensitization by indolocarbazole derivatives

    The Regents of the University of California Β· Granted May 2, 2006 Β· Expires Apr 27, 2026

    expired
  18. US 7037583

    Functionalized zirconium oxide particles

    The Board of Regents of the University of Texas System Β· Granted May 2, 2006 Β· Expires Apr 27, 2026

    expired
  19. US 7037534

    Inactivation of viral infections agents by chemiluminescence activated light-sensitive compounds

    Aphios Corporation Β· Granted May 2, 2006 Β· Expires Apr 27, 2026

    expired
  20. US 7037499

    Adjuvant for transcutaneous immunization

    The United States of America as represented by the Secretary of the Army Β· Granted May 2, 2006 Β· Expires Apr 27, 2026

    expired
  21. US 7037501

    Myostatin immnoconjugate

    Regents of the University of Minnesota Β· Granted May 2, 2006 Β· Expires Apr 27, 2026

    expired
  22. US 7037680

    Recombinant light chains of botulinum neurotoxins and light chain fusion proteins for use in research and clinical therapy

    The United States of America as represented by the Secretary of the Army Β· Granted May 2, 2006 Β· Expires Apr 27, 2026

    expired
  23. US 7038085

    Stereoisomers of p-hydroxy-milnacipran, and methods of use thereof

    Collegium Pharmaceutical, Inc. Β· Granted May 2, 2006 Β· Expires Apr 27, 2026

    expired
  24. US 7037916

    Pyrimidine derivatives as IL-8 receptor antagonists

    Pharmacopeia Drug Discovery, Inc. Β· Granted May 2, 2006 Β· Expires Apr 27, 2026

    expired

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search β€” best for looking up a specific filing or applicant portfolio slice.